Equities

ARCpoint Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ARC:CVE

ARCpoint Inc

Actions
  • Price (CAD)0.01
  • Today's Change0.00 / 0.00%
  • Shares traded408.00k
  • 1 Year change-90.00%
  • Beta-2.0816
Data delayed at least 15 minutes, as of Feb 06 2026 20:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

ARCpoint Inc. is a healthcare company that leverages technology along with brick-and mortar locations to give businesses and individual consumers access to healthcare information and solutions. The Company, through its subsidiary, ARCpoint Corporate Labs LLC, develops corporate-owned labs focused on providing solutions for customers, businesses and physicians. The Company, through its subsidiary, AFG Services LLC, serves as the innovation center of the ARCpoint group of companies as it builds a proprietary technology platform and a physician network to equip all ARCpoint labs with tools and solutions to serve their customers. The platform also digitalizes and streamlines administrative functions such as materials purchasing, compliance, billing and physician services for ARCpoint franchise labs and other clients. The Company maintains a 29.5% ownership in CRESSO Brands LLC, a United States-based franchise system which offers diagnostic testing and employer solutions.

  • Revenue in CAD (TTM)5.52m
  • Net income in CAD2.98m
  • Incorporated2022
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Newtopia Inc6.71m-7.26m858.41k100.00------0.1279-0.044-0.0440.0402-0.07272.2032.186.37---238.08-144.42----49.8848.74-108.09-81.390.043-1.52-----12.3826.0614.29---42.99--
Jack Nathan Medical Corp7.47m604.88k863.03k24.001.449.710.76390.11560.0070.12410.08570.0011.73--7.38--14.03-73.5055.95-132.35----8.10-64.38---7.380.6968--26.4119.20-89.79--35.78--
Element Lifestyle Retirement Inc1.12m64.19k1.05m--16.48--14.350.93420.00090.00090.0159-0.00990.8803--10.76--5.04-31.866.74-36.52----5.72-50.68--0.55821.68--2.6554.8955.95---38.07--
ARCpoint Inc5.52m2.98m1.27m--0.31--0.33890.23050.03230.03230.0497-0.13040.9099--6.94--49.85------69.27--54.79-----12.715.96---17.43--115.67------
Universal Ibogaine Inc2.06m-1.48m1.55m----5.67--0.7523-0.0052-0.00520.00690.00090.4419--4.99---31.67---47.71--17.31---71.66-----4.880.9043--126.32--14.17------
AJA Health And Wellness Inc131.10k-3.26m3.01m----1.23--22.93-0.175-0.1750.00520.02850.0774-------192.06-62.76---343.4961.94---2,483.09-578,671.90---1.890.0562-------146.86------
Leveljump Healthcare Corp18.91m1.99m6.21m--4.171.001.900.32860.01560.01560.16690.06580.9354--16.09--9.85-30.0113.56-41.3820.4718.4010.53-28.34--0.55820.649--40.9126.97152.5661.40199.61--
Data as of Feb 06 2026. Currency figures normalised to ARCpoint Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.